Table 4

 Mean difference in lung function measures in non-placebo controlled studies (positive number favours the 200 µg dose)

WeeksFEV1 (l)PEF—am (l/min)PEF—pm (l/min)
*From reference 21; data expressed as mean (SE).
†From reference 20; data expressed as mean (95% CI).
200 v 100 µg*26−3.0(3.5)10.7 (7.4)13.1 (6.4)
200 v 400 µg †52−11.4 (−5.6 to −17.3)−11.9 (−6.2 to −17.6)
200 v 1000 µg*83.6(3.1)5.2 (8.9)2.5 (8.3)